Kailera Therapeutics(KLRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KLRA Kailera Therapeutics

Pre-Mkt 07-10 09:29:08 EDT

21.01

-0.75

-3.45%

盘前21.99

+0.98+4.66%

07:06 EDT

High21.70	Low20.58	Vol701.62K
Open21.49	D1 Closing21.76	Amplitude5.15%
Mkt Cap2.72B	Tradable Cap943.81M	Total Shares129.54M
T/O14.76M	T/O Rate1.56%	Tradable Shares44.92M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"KLRA","market":"US","secType":"STK","nameCN":"Kailera Therapeutics","latestPrice":21.01,"timestamp":1783627200000,"preClose":21.76,"halted":0,"volume":701616,"hourTrading":{"tag":"盘前","latestPrice":21.99,"preClose":21.01,"latestTime":"07:06 EDT","volume":31,"amount":656.970011,"timestamp":1783681563590,"change":0.98,"changeRate":0.046644,"amplitude":0.047063},"delay":0,"changeRate":-0.03446691176470588,"floatShares":44921899,"shares":129537300,"eps":-1.204378,"marketStatus":"Pre-Mkt","change":-0.75,"latestTime":"07-10 09:29:08 EDT","open":21.485,"high":21.7,"low":20.58,"amount":14763465.614208,"amplitude":0.051471,"askPrice":22.71,"askSize":1,"bidPrice":20,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-1.204378,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1783690200000},"marketStatusCode":1,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":21.01,"preHourTrading":{"tag":"盘前","latestPrice":21.99,"preClose":21.01,"latestTime":"07:06 EDT","volume":31,"amount":656.970011,"timestamp":1783681563590,"change":0.98,"changeRate":0.046644,"amplitude":0.047063},"postHourTrading":{"tag":"盘后","latestPrice":21.01,"preClose":21.01,"latestTime":"19:26 EDT","volume":3414,"amount":71736.2,"timestamp":1783639567190,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.749318195671087},"requestUrl":"/m/hq/s/KLRA/wiki","defaultTab":"wiki","newsList":[{"id":"2650152659","title":"Kailera Therapeutics Files Form 3 for Chief Corporate Affairs Officer Kathleen Tregoning","url":"https://stock-news.laohu8.com/highlight/detail?id=2650152659","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650152659?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:16","pubTimestamp":1783541765,"startTime":"0","endTime":"0","summary":"Kailera Therapeutics files Form 3 for Chief Corporate Affairs Officer Kathleen TregoningKailera Therapeutics named Kathleen Tregoning as chief corporate affairs officer in an initial Form 3 filing dat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL8l21D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLRA","OZEM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649099976","title":"Jefferies Keeps Their Buy Rating on Kailera Therapeutics, Inc. (KLRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649099976","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649099976?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:35","pubTimestamp":1783517747,"startTime":"0","endTime":"0","summary":"In a report released today, Roger Song from Jefferies maintained a Buy rating on Kailera Therapeutics, Inc., with a price target of $48.00. Song co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-keeps-their-buy-rating-on-kailera-therapeutics-inc-klra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-keeps-their-buy-rating-on-kailera-therapeutics-inc-klra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649346689","title":"Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (ACHC) and Kailera Therapeutics, Inc. (KLRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649346689","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649346689?lang=en_us&edition=fundamental","pubTime":"2026-07-08 01:30","pubTimestamp":1783445416,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Acadia Healthcare (ACHC) and Kailera Therapeutics, Inc. (KLRA). A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-acadia-healthcare-achc-and-kailera-therapeutics-inc-klra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-acadia-healthcare-achc-and-kailera-therapeutics-inc-klra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4585","ACHC","BK4581","KLRA","LABU","XLV","OZEM","BK4139","BK4185","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649402939","title":"Race to Launch Weight-loss Pills Heats up as Smaller Players Advance","url":"https://stock-news.laohu8.com/highlight/detail?id=2649402939","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649402939?lang=en_us&edition=fundamental","pubTime":"2026-07-08 00:12","pubTimestamp":1783440755,"startTime":"0","endTime":"0","summary":"FACTBOX-Race to launch weight-loss pills heats up as smaller players advanceAdds details of Kailera Therapeutics' obesity drug in paragraphs 1,2 and 25July 7 (Reuters)-Kailera Therapeutics'KLRA.Ooral ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N4391DU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU1162221912.USD","IE00BWXC8680.SGD","LU0198837287.USD","LU1804176565.USD","LU1037948897.HKD","LU2471134879.HKD","LU0787776722.HKD","BK4581","LU0029864427.USD","LU0320765489.SGD","SGXZ51526630.SGD","MEDX","LU2456880835.USD","LU2097828631.EUR","LU2461242641.AUD","IE0004445015.USD","LU0109394709.USD","BK4516","LU2063271972.USD","SG9999015986.USD","LU0321505868.SGD","CANC","SG9999014914.USD","SG9999003800.SGD","ILDR","PAWZ","LU1066051498.USD","LU2237443978.SGD","LU2106854487.HKD","IHE","LU1057294990.SGD","LU0316494557.USD","LU0122379950.USD","LU1127390331.HKD","IE0001KFT4U8.USD","LLYZ","LU0266013472.USD","LU1201861249.SGD","LU0234572021.USD","LU0965509010.AUD","SG9999001176.SGD","LU0353189680.USD","LU2746668974.SGD","LU1623119135.USD","LU1069347547.HKD","IE00BJLML261.HKD","HK0000165453.HKD","LU0133085943.USD","LU0943347566.SGD","LU1988902786.USD","GPCR","LU2468319806.SGD","LU2896262040.SGD","LU2265009873.SGD","BK1574","LU0889565916.HKD","SG9999015341.SGD","AZNH","BK4588","LU1868836591.USD","SGXZ57979304.SGD","LU2168563687.JPY","LU0708994859.HKD","LU2361045086.USD","LU0417517546.SGD","IE00B7KXQ091.USD","LU0353189763.USD","LU1712237335.SGD","LU1917777945.USD","LU0868494617.USD","LU0502904849.HKD","LU0861579265.USD","LU0070302665.USD","LU1145028129.USD","LU0965508806.USD","LU2552382058.USD","LU2168564149.EUR","SG9999017495.SGD","LU0882574139.USD","LU0225284248.USD","FHLC","LU2211815571.USD","LU0238689110.USD","LU1035773651.USD","LU1366192091.USD","LU2360032135.SGD","IYH","IE00BK4W5L77.USD","BK4592","IE00BK4W5M84.HKD","LU0345770308.USD","LU0965509101.SGD","SG9999018857.SGD","KLRA","LU2108987350.USD","LU0158827948.USD","LU0170899867.USD","SG9999018865.SGD","IE00B4R5TH58.HKD","IE00BN29S564.USD","LU2097828714.EUR","LU1035775433.USD","LU2361044949.HKD","LU1066051225.USD","LU1934455277.USD","SG9999002232.USD","XLV","LU0203202063.USD","IE00BKVL7J92.USD","LU0320765646.SGD","LU0096364046.USD","LU2242644610.SGD","LU2087625088.SGD","LU2028103732.USD","LU0128525929.USD","SG9999015358.SGD","LU0079474960.USD","LU1989772923.USD","LU1923622614.USD","LU2361044865.SGD","LU1974910355.USD","SG9999001440.SGD","LU0820561818.USD","LU2471134952.CNY","LU1037948541.HKD","LU0683600562.USD","MEDI","BK4559","LU1941712348.USD","NVOX","LU2125154935.USD","LU2491049909.HKD","LU1934455194.USD","HRTS","LU2357305700.SGD","NVOH","LU0456855351.SGD","LU2756315664.SGD","LU0203347892.USD","LU1894683264.USD","LU2125909247.SGD","LU0708995401.HKD","LU1989772840.SGD","LU0154236417.USD","LU0306807586.USD","IE00BJT1NW94.SGD","LU2168564495.EUR","LU2360106947.USD","LU2750360641.GBP","SG9999014906.USD","LU0432979614.USD","LU0823416689.USD","IE00B3T34201.USD","LU2491050154.USD","LU2271345857.HKD","IE000M9KFDE8.USD","LU1720051108.HKD","LU0210536198.USD","SG9999014880.SGD","LU0265550359.USD","LU1066051811.HKD","LU0225283273.USD","LU2264538146.SGD","LU2023251221.USD","LU1430594728.SGD","LU0323591593.USD","LU0985320562.USD","ELIS","LU1868836914.USD","BK4532","LU0964807845.USD","LU0256863902.USD","SG9999015945.SGD","LU2552382215.SGD","LU0345770993.USD","SG9999014542.SGD","LU1941712264.USD","BK4533","LU1093756325.SGD","LU1814569148.SGD","LU1551013425.SGD","LU1023059063.AUD","LU0058720904.USD","LU2089984988.USD","LU1989771016.USD","IE00BJJMRY28.SGD","IXJ","SG9999015952.SGD","VKTX","LU0820561909.HKD","IE00B1XK9C88.USD","IE00B1BXHZ80.USD","LU0820562030.AUD","IE00BFTCPJ56.SGD","LU0942090050.USD","LU2111349929.HKD","THNR","SGXZ99366536.SGD","LU2756315318.SGD","LU1267930730.SGD","LU1929549753.HKD","LU1551013342.USD","LU0882574055.USD","LU2471134796.USD","LU1093756168.USD","LU0868494708.USD","LU0385154629.USD","LU0109391861.USD","LU2750360997.AUD","IE00BLSP4239.USD","KURE","LU0203201768.USD","IE00BJJMRZ35.SGD","JDOC","LU2237443895.HKD","LU1720051017.SGD","SG9999014559.SGD","VHT","01801","IE00B19Z3581.USD","LU0289739699.SGD","LU0640476718.USD","LU0225771236.USD","LU1064131342.USD","IE00B19Z3B42.SGD","IE0005OL40V9.USD","LU2089284900.SGD","LU0097036916.USD","PFE","BK4550","LU0321505439.SGD","GB00BDT5M118.USD","SG9999013999.USD","BK4534","IE0009355771.USD","LU2237438978.USD","SG9999011175.SGD","IE00BZ1G4Q59.USD","LU2168564222.USD","LU1699723380.USD","LU0455707207.USD","LU0648001328.SGD","GDOC","OZEM","LU2328871848.SGD","LU1883839398.USD","FTXH","LU0208291251.USD","LU0006306889.USD","LU0114720955.EUR","LU2097828805.USD","LU0320765992.SGD","LU2023250504.SGD","LU2237443549.SGD","LU0965509283.SGD","LU2471134523.USD","LU1280957306.USD","LU0471298694.HKD","LU2237443382.USD","BK1583","LU2552382132.HKD","LU0471298777.SGD","MRK","LU1868836757.USD","NVO","IE00BLSP4452.SGD","BMED","LU2112291526.USD","LU0354030511.USD","AGNG","LU1066053197.SGD","LU2023250330.USD","LU0256863811.USD","BK4599","LU0354030438.USD","LU0130102774.USD","RXL","LU2491050071.SGD","LU0306806265.USD","SGXZ81514606.USD","SG9999014575.USD","IE0002270589.USD","LU0689472784.USD","LU2433249047.HKD","IE00BKPKM429.USD","LU1323610961.USD","SG9999015978.USD","BK1515","LU1585245621.USD","LU2746668461.USD","IE00BKDWB100.SGD","LU1116320737.USD","IE00BFSS8Q28.SGD","AZN","LU0061475181.USD","IE00B2B36J28.USD","LU1829250122.USD","LU0130517989.USD","PJP","LU1116320901.HKD","IE0004445239.USD","LU1969619763.USD","IE0002141913.USD","BK4568","SGXZ31699556.SGD","LU2488822045.USD","LU1291159041.SGD","LLII","LU2237443465.HKD","IE00BFSS7M15.SGD","SG9999014567.USD","LU0211331839.USD","CURE","LU2602419157.SGD","BK1161","LU1868837300.USD","LU2236285917.USD","LU2023250843.SGD","LU0672654240.SGD","IE00B4JS1V06.HKD","WDNA","LU0265550946.USD","LU2097828474.EUR","LU0466842654.USD","LLY","LU1983299246.USD","LU1629891620.HKD","IE00BBT3K403.USD","LU0158827781.USD","LU0823434583.USD","LU0203345920.USD","LU2168564065.EUR","LU1232071149.USD","LU2097828557.USD","LU0477156953.USD","LU2417539215.USD","LU1548497426.USD","BK4585","LU2596442595.SGD","IE00BJJMRX11.SGD","LU0985481810.HKD","LU1069344957.HKD","LU2324357040.USD","IE00BN8TJ469.HKD","LU2462157665.USD","LU0098860793.USD","LU0980610538.SGD","LU1571399168.USD","LU2357627491.SGD","LU2089283258.USD","BK4007","IE00BSNM7G36.USD","LU1868837136.USD","LU2125154778.USD","SG9999001176.USD","LU0859254822.USD","PPH","LU0320765059.SGD","LU1934455863.HKD","LU1267930573.SGD","LLYX","SG9999014898.SGD","LU0106261372.USD","LU2213496289.HKD","ELIL","BK4139","SG9999002224.SGD","LU0786609619.USD","LU1061106388.HKD","LU0310800379.SGD","LU0823434740.USD","LU0094547139.USD","LU2125909593.SGD","LU1894683348.USD","01672","LU2237443622.USD","IE00B775H168.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649352259","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2649352259","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649352259?lang=en_us&edition=fundamental","pubTime":"2026-07-07 22:40","pubTimestamp":1783435211,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Kailera Therapeutics, Inc. (KLRA) and Revolution Med...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-246?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-246?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OZEM","KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649933246","title":"Kailera Therapeutics announces positive Phase 3 data for weight loss drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2649933246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649933246?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:35","pubTimestamp":1783431310,"startTime":"0","endTime":"0","summary":"Kailera Therapeutics (KLRA) announced positive topline results from two Phase 3 clinical trials conducted by its partner, Hengrui Pharma, evaluatin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kailera-therapeutics-announces-positive-phase-3-data-for-weight-loss-drug-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kailera-therapeutics-announces-positive-phase-3-data-for-weight-loss-drug-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HYLG","IDNA","MEDX","OZEM","BMED","GDOC","BK4139","KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984022","title":"Shares of Kailera Therapeutics up 1.9% Premarket After Weight-loss Drug Meets Main Goal of Late-stage Trials in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984022?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:31","pubTimestamp":1783423890,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nFWN4390HR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OZEM","KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649162984","title":"Kailera Shares Tumble on High Nausea Rates Despite Weight-loss Drug's Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2649162984","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649162984?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:21","pubTimestamp":1783423300,"startTime":"0","endTime":"0","summary":"UPDATE 3-Kailera shares tumble on high nausea rates despite weight-loss drug's successJuly 7 (Reuters)-Kailera Therapeutics'KLRA.Oshares dropped 10% on Tuesday after its oral weight-loss drug showed h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N4390VP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLRA","SGXZ57979304.SGD","LU0310799852.SGD","LU1989771016.USD","LU0266013472.USD","IE00B4R5TH58.HKD","03165","LU0496365809.HKD","LU1078025761.USD","LU0957799991.USD","LU0171276677.USD","LU0310800965.SGD","OZEM","LU0211327993.USD","LU2237443978.SGD","LU1880407215.USD","LU2097828805.USD","LU2097828631.EUR","LU0203345920.USD","LU0211326839.USD","LU1781817850.SGD","LU0784384876.USD","LU0976567544.SGD","LU2089284900.SGD","LU0345777659.USD","LU1273509221.SGD","LU0972486137.USD","LU0889566641.SGD","LU1267930227.SGD","LU0289739699.SGD","LU1328615791.USD","LU1267930813.SGD","AZN.UK","LU2237443549.SGD","LU0949170426.SGD","IE0034235188.USD","600276","LU0405327494.USD","LU2324357040.USD","LU1146622755.USD","LU2097828557.USD","LU2293690249.USD","LU2237443622.USD","LU0960981461.USD","SG9999001176.USD","LU1481600234.SGD","BK0188","LU1046234339.USD","LU1064130708.USD","LU0526926950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984887","title":"Kailera's GLP-1 Drug Meets Main Goal of Late-stage Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984887","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984887?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:06","pubTimestamp":1783422405,"startTime":"0","endTime":"0","summary":"Kailera's GLP-1 drug meets main goal of late-stage trialsJuly 7 (Reuters)-Kailera TherapeuticsKLRA.Osaid on Tuesday its GLP-1 drug for patients with diabetes and obesity met the main goal of two-late stage trials.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N4390VA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OZEM","BK4139","KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649398103","title":"Kailera Reports Phase 3 China Data Showing up to 10.9% Weight Loss with Oral GLP-1 Drug Kai-7535","url":"https://stock-news.laohu8.com/highlight/detail?id=2649398103","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649398103?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:02","pubTimestamp":1783422136,"startTime":"0","endTime":"0","summary":"Kailera reports Phase 3 China data showing up to 10.9% weight loss with oral GLP-1 drug KAI-7535Kailera reported positive topline Phase 3 results in China for oral GLP-1 agonist HRS-7535, also known a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL1K8vr9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","03145","LU0096374516.USD","LU2210150020.SGD","IE00B64PRP62.GBP","80016","IE00B1G9TM23.USD","LU2210149790.SGD","BK1601","LU2088748020.USD","LU2088748293.HKD","IE00BGHQF748.EUR","LU1163227579.USD","03121","BK1559","BK4585","LU2226123490.SGD","00016","SUHJY","BK1216","IE00BKPKM429.USD","IE00BSPPW651.USD","NDAQ","OZEM","LU1163227496.USD","BCDF","SG9999009997.SGD","BK4588","SG9999014005.SGD","LU2226123227.USD","LU0315179316.USD","BK1521","LU0229494975.USD","LU0886674414.USD","LU2088747998.USD","SG9999002463.SGD","LU1316543674.SGD","LU1504937902.USD","KLRA","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","LU2088748376.SGD","SG9999010052.SGD","BK4112","SG9999014021.USD","LU2095319765.USD","IE00BN0W2W23.USD","LU1560770973.SGD","LU0061477393.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649981789","title":"Kailera Therapeutics - Hrs-7535 Lowers Hba1c by 1.5%-1.68% in Phase 3 Type 2 Diabetes Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2649981789","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649981789?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:00","pubTimestamp":1783422004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA6FTSWX:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KLRA","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649981749","title":"Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule Glp-1 Receptor Agonist Hrs-7535/kai-7535","url":"https://stock-news.laohu8.com/highlight/detail?id=2649981749","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649981749?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:00","pubTimestamp":1783422004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA6FTSWX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OZEM","KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649817599","title":"Kailera Therapeutics Inc: Advancing Kai-7535 in a Global Phase 2 Clinical Trial in People Living with Obesity or Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2649817599","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649817599?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:00","pubTimestamp":1783422004,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA6FTSWX:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KLRA","OZEM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649598173","title":"Kailera Therapeutics Inc: Kai-7535 Trial Initiated in April 2026, with Data Expected in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2649598173","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649598173?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:00","pubTimestamp":1783422004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA6FTSWX:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KLRA","BK4139","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649498176","title":"Kailera Therapeutics - no Liver Safety Signals Observed in Phase 3 Trials of Hrs-7535","url":"https://stock-news.laohu8.com/highlight/detail?id=2649498176","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649498176?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:00","pubTimestamp":1783422004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA6FTSWX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KLRA","BK4139","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647537613","title":"Press Release: Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2647537613","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647537613?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:30","pubTimestamp":1782732600,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., June 29, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc., a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced the appointment ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641812390","title":"Kailera Therapeutics - Phase 2 Ribupatide Oral Shows up to 12.1% Mean Weight Loss at 26 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2641812390","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641812390?lang=en_us&edition=fundamental","pubTime":"2026-06-06 07:37","pubTimestamp":1780702671,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nFWN42D0RY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KLRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641123920","title":"Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2641123920","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641123920?lang=en_us&edition=fundamental","pubTime":"2026-06-06 07:32","pubTimestamp":1780702320,"startTime":"0","endTime":"0","summary":"Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as a once-weekly injection and a once-daily oral pill for the treatment of obesity and ove","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/05/3307661/0/en/Hengrui-Pharma-and-Kailera-Therapeutics-Present-Ribupatide-Clinical-Data-at-ADA-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PD","BK4218","LU1169589451.USD","BK4139","AUC","LU1169590202.USD","PK","BK4181","BK4023","KLRA","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639168796","title":"Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2639168796","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639168796?lang=en_us&edition=fundamental","pubTime":"2026-05-29 04:05","pubTimestamp":1779998700,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., May  28, 2026  (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA), a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/28/3303260/0/en/Kailera-Therapeutics-to-Present-at-the-2026-Jefferies-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","BK4588","LU0128526141.USD","BK4585","HCSG","KLRA","XBI","BK4139","LABU","LU0029874061.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639697868","title":"Jefferies Sticks to Their Buy Rating for Kailera Therapeutics, Inc. (KLRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2639697868","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639697868?lang=en_us&edition=fundamental","pubTime":"2026-05-28 23:55","pubTimestamp":1779983733,"startTime":"0","endTime":"0","summary":"Jefferies analyst Roger Song maintained a Buy rating on Kailera Therapeutics, Inc. today and set a price target of $48.00. Song covers the Healthca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-their-buy-rating-for-kailera-therapeutics-inc-klra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-their-buy-rating-for-kailera-therapeutics-inc-klra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KLRA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kailera.com","stockEarnings":[{"period":"1week","weight":-0.0446},{"period":"1month","weight":0.0698},{"period":"3month","weight":0.3131},{"period":"ytd","weight":0.3131}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":0.0199},{"period":"3month","weight":0.1063},{"period":"6month","weight":0.083},{"period":"1year","weight":0.2045},{"period":"ytd","weight":0.1023}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Kailera Therapeutics","nameEN":"Kailera Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kailera Therapeutics(KLRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Kailera Therapeutics(KLRA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Kailera Therapeutics,KLRA,Kailera Therapeutics股票,Kailera Therapeutics股票老虎,Kailera Therapeutics股票老虎国际,Kailera Therapeutics行情,Kailera Therapeutics股票行情,Kailera Therapeutics股价,Kailera Therapeutics股市,Kailera Therapeutics股票价格,Kailera Therapeutics股票交易,Kailera Therapeutics股票购买,Kailera Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kailera Therapeutics(KLRA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Kailera Therapeutics(KLRA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction